Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.1B | 4.2B | 1.7B | 2.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 275M | 214M | 228M | 335M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 44M | 51M | 49M | 43M |
| Other income expense | 179M | 186M | 220M | 184M |
| Pretax income | -258M | 818M | -409M | -42M |
| Tax provision | -55M | 167M | -77M | -289M |
| Net income | -203M | 651M | -332M | 247M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | -203M | 651M | -332M | 247M |
| Minority interests | — | -2M | 44M | -3M |
| Preferred stock dividends | — | — | — | — |